File(s) under permanent embargo
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
journal contribution
posted on 2021-08-01, 00:00 authored by G Morris, Ken WalderKen Walder, S Kloiber, P Amminger, Michael BerkMichael Berk, Chiara BortolasciChiara Bortolasci, M Maes, B K Puri, A F CarvalhoThe endocannabinoidome in neuropsychiatry: Opportunities and potential risks
History
Journal
Pharmacological ResearchVolume
170Article number
105729Pagination
1 - 24Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
ISSN
1043-6618eISSN
1096-1186Language
engPublication classification
C1 Refereed article in a scholarly journalUsage metrics
Categories
No categories selectedKeywords
Affective disordersBipolar disorderDepressionEndocannabinoid receptorsNeurodegenerationNeuro-immuneNeuroscienceNeurotoxicityOxidative stressPsychiatrySchizophreniaScience & TechnologyLife Sciences & BiomedicinePharmacology & PharmacyCANNABINOID CB2 RECEPTORACID AMIDE HYDROLASELONG-TERM DEPRESSIONPROTEIN-COUPLED RECEPTORMESSENGER-RNA EXPRESSIONEXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITISDIACYLGLYCEROL-LIPASE-ALPHAINDUCED INSULIN-RESISTANCEHETEROTRIMERIC G-PROTEINSBLOOD-BRAIN-BARRIER
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC